Entourage Health Corp. announced today its financial results for the three months ended March 31, 2022.

Entourage Health Corp. and The Boston Beer Company, Inc. are pleased to announce the Canadian debut of ‘TeaPot’, a new line of cannabis-infused iced tea beverages.

Entourage Health Corp. announced today that it is scheduled to file its first quarter 2022 financial statements and management’s discussion and analysis after-market on Monday, May 30, 2022.

Entourage Health Corp. is pleased to announce that it has entered into voting support agreements with certain holders of the Company’s 8.5% unsecured convertible debentures due September 25, 2022…

Entourage Health Corp. announced today that George Scorsis, CEO and Executive Chair, and Vaani Maharaj, Chief Financial Officer, are scheduled to present at the Canaccord Genuity 6th Annual Global Cannabis Virtual Conference on Thursday, May 11th at 1 p.m. ET.

Entourage Health Corp. announced today its financial results for the fiscal year ended December 31, 2021.

Entourage Health Corp. announced today that the Ontario Securities Commission (the “OSC”) has issued a Cease Trade Order (the “CTO”) as a result of the Company not filing its financial statements for the year ended December 31, 2021 and the related management’s discussion and analysis and CEO and CFO certifications (collectively, the “Annual Filings”) by May 2, 2022, being the date that such filings were due under applicable Canadian securities laws.

Entourage Health Corp. announced today it has entered into an agreement with Fire & Flower Holdings Corp., a leading cannabis consumer retail and technology platform and its wholly owned delivery and logistics subsidiary, Pineapple Express Delivery Inc. to offer same-day and next-day delivery services to the Company’s Starseed Medicinal patients.

Entourage Health Corp. announced today it will defer its fourth quarter and full-year 2021 press release and conference call previously scheduled for May 3, 2022, to coincide with its projected first quarter 2022 financial results, expected on or before May 31, 2022.

Entourage Health Corp. is pleased to announce it has amended and upsized its existing credit facility with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada, adding an additional $15 million in funding availability.

Entourage Health Corp. announced today that it will file its fourth quarter and full-year 2021 financial statements and management’s discussion and analysis after-market on Monday May 2, 2022.

Entourage Health Corp. confirmed today it has signed an additional amendment to its senior secured credit facility entered into on March 29, 2019.

Pre-roll products available at Ontario retail stores via the Company’s craft brand Royal City Cannabis Co., with $1 of every pre-roll sold going to the advancement of Cannabis Amnesty’s initiatives

Entourage Health Corp. is pleased to announce the appointment of Vaani Maharaj, a seasoned financial executive with broad experience in corporate finance, healthcare and consumer-packaged goods (CPG).

On this International Women’s Day, the Company proudly spotlights its all-female trade and brand marketing team behind the 2022 launch of “Just add Color” anchored in colour theory

Company also provides a corporate update and confirms George Scorsis as permanent CEO

Includes Ontario launch of specialty concentrate product “Pedro’s Sweet Sativa Live Sugar”; debut of high-THC, rare cultivar “Space Cake”; and “Black Sugar Rose 10-pack Pre-rolls”

Entourage Health issued an open letter to shareholders today to provide a recap of its corporate and operational achievements attained over the past year, and an overview of what is expected in 2022.

Funding to enhance cultivation growth with tissue culture and market new genetics with premium products via Color Cannabis, Royal City Cannabis, Saturday Cannabis and Starseed Medicinal

Company also confirms its certification as an Ontario Living Wage Employer, becoming one of only three cannabis cultivators with this distinction